Academic Journal
Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study
| العنوان: | Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study |
|---|---|
| المؤلفون: | Doorduijn, Jeanette, van Imhoff, GW, van der Holt, Ronnie, Schouten, HC, Schaafsma, MR, MacKenzie, MA, Baars, JW, Kersten, MJ, Lugtenburg, Elly, van den Bent, Martin, Enting, RH, Spoelstra, Fokje, Poortmans, P, Bromberg, Jacoline |
| المصدر: | Doorduijn , J , van Imhoff , GW , van der Holt , R , Schouten , HC , Schaafsma , MR , MacKenzie , MA , Baars , JW , Kersten , MJ , Lugtenburg , E , van den Bent , M , Enting , RH , Spoelstra , F , Poortmans , P & Bromberg , J 2017 , ' Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study ' , Hematological Oncology , vol. 35 , .... |
| سنة النشر: | 2017 |
| مصطلحات موضوعية: | /dk/atira/pure/keywords/researchprograms/AFL001000/EMCOR01, name=EMC OR-01 |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | unknown |
| DOI: | 10.1002/hon.2342 |
| الاتاحة: | https://pure.eur.nl/en/publications/c2ad26dd-332f-44e8-b62d-f291ee50806e https://doi.org/10.1002/hon.2342 http://hdl.handle.net/1765/96349 |
| Rights: | info:eu-repo/semantics/closedAccess |
| رقم الانضمام: | edsbas.378838A9 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1002/hon.2342 |
|---|